![]() |
|
|
Vol. 60, Issue 4, 761-767, October 2001
í and
ek
Institute of Physiology, Academy of Sciences of the Czech Republic,
Prague, Czech Republic
To clarify the involvement of specific domains of muscarinic receptors
in the action of allosteric modulators, muscarinic M3
receptors (on which allosteric interactions are weak) were genetically
modified to become more similar to M2 receptors (on which
allosteric interactions are strong) and were expressed in COS-7 cells.
Affinity for allosteric modulator gallamine was enhanced 25- to 50-fold
by modifications of the third external loop (o3) and the negative
effect of gallamine on the affinity for classical antagonist
N-[3H]methylscopolamine
([3H]NMS) was augmented. Affinity for alcuronium became
3-fold higher after the o3 loop of M3 receptors was made
identical with the o3 loop of M2 receptors, and alcuronium
acquired positive influence on the affinity for [3H]NMS.
This is the first instance of inducing positive cooperativity on
muscarinic receptors by genetic manipulation. Transferring whole o2
loop from M2 to M3 receptors substantially
enhanced affinities for gallamine and alcuronium without augmenting
their negative action on [3H]NMS binding. In contrast,
effects of simply adding two negative charges into the o2 loop of
M3 receptors were small. Removal of Arg from o1 loop
abolished the negative effect of gallamine but not of alcuronium on
[3H]NMS binding at equilibrium. Data point to an
important role of o3 loop in the mechanism of the positive and negative
cooperativity between [3H]NMS and alcuronium and
gallamine, respectively, and in the binding of both modulators to
M2 receptors and reveal independence between mutation-induced changes in the affinity for a modulator and in the
magnitude and direction of the allosteric effect of the modulator.
This article has been cited by other articles:
![]() |
W. Y. Chan, D. L. McKinzie, S. Bose, S. N. Mitchell, J. M. Witkin, R. C. Thompson, A. Christopoulos, S. Lazareno, N. J. M. Birdsall, F. P. Bymaster, et al. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia PNAS, August 5, 2008; 105(31): 10978 - 10983. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Mazzone, N. Mori, M. Burman, M. Palovich, K. E. Belmonte, and B. J. Canning Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy J. Physiol., August 15, 2006; 575(1): 23 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prilla, J. Schrobang, J. Ellis, H.-D. Holtje, and K. Mohr Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity Mol. Pharmacol., July 1, 2006; 70(1): 181 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7 Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Huang, S. Prilla, K. Mohr, and J. Ellis Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide Mol. Pharmacol., September 1, 2005; 68(3): 769 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jakubik, A. Krejci, and V. Dolezal Asparagine, Valine, and Threonine in the Third Extracellular Loop of Muscarinic Receptor Have Essential Roles in the Positive Cooperativity of Strychnine-Like Allosteric Modulators J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 688 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-Y. Zeng, A. J. McLean, G. Milligan, M. Lerner, D. T. Chalmers, and D. P. Behan Ligand Specific Up-Regulation of a Renilla reniformis Luciferase-Tagged, Structurally Unstable Muscarinic M3 Chimeric G Protein-Coupled Receptor Mol. Pharmacol., December 1, 2003; 64(6): 1474 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Voigtlander, K. Johren, M. Mohr, A. Raasch, C. Trankle, S. Buller, J. Ellis, H.-D. Holtje, and K. Mohr Allosteric Site on Muscarinic Acetylcholine Receptors: Identification of Two Amino Acids in the Muscarinic M2 Receptor That Account Entirely for the M2/M5 Subtype Selectivities of Some Structurally Diverse Allosteric Ligands in N-Methylscopolamine-Occupied Receptors Mol. Pharmacol., July 1, 2003; 64(1): 21 - 31. [Abstract] [Full Text] [PDF] |
||||